Research and Practice in Alzheimer's Disease, Volume 3Serdi Publisher, 2000 - Alzheimer's disease |
Contents
towards a new therapy option with memantine | 241 |
Future scenarios for the prevention and delay of Alzheimer Disease | 267 |
Efficacy and Safety | 305 |
Copyright | |
1 other sections not shown
Other editions - View all
Common terms and phrases
3MSE AChE activity ADAS-cog Alzheimer disease Alzheimer's disease amyloid ApoE apolipoprotein Aẞ assessment associated baseline brain Ca2+ carbamazepine Cerebrolysin changes ChEI cholinergic cholinesterase inhibitors CIBIC-Plus clinical trials cognitive decline cognitive function control group correlation cortex cortical criteria decrease deficits delirium demented dementia depression diagnosis disorders donepezil drugs effects efficacy elderly estrogen euros evaluated family caregivers fMRI geriatric global glutamate Health hippocampal improvement increase inhibition intervention Key words levels lipoproteins markers melatonin Memantine memory metrifonate mg/day microglia mild cognitive impairment MMSE neurodegeneration Neurology neurons nicotinic normal aging Notch NSAID nursing home nutritional onset outcome oxidation pathology patients performance placebo plaques predictors Presenilin processes protein Psychiatry receptor risk factors rivastigmine sample schizophrenia score Serdi significant significantly sleep special care unit subjects suggest symptoms synaptic tacrine tasks therapeutic therapy treatment vascular wandering week weight loss Wesnes